Ahencio, Belen A.
HRN: 26-18-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/10/2024
11/16/2024
IV
600mg
Q8
DM Foot, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes